Bookmark

Add to MyYahoo RSS

Cerezyme, Imiglucerase News

News on Cerezyme, Imiglucerase (generic) continually updated from thousands of sources around the net.

Yesterday | Hispanic Business

FDA Approves ELELYSO(TM); Auxilium To Present CCH Data For AUX-CC-867 MULTICORD

ELELYSO is therefore now indicated for long-term enzyme replacement therapy for adult and pediatric patients with a confirmed diagnosis of Type 1 Gaucher disease.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Medicine, Genetics

Thursday | Pharmaceutical Processing

Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSOa

Pfizer and Protalix BioTherapeutics announced that the U.S. Food and Drug Administration approved ELELYSOTM for injection for pediatric patients.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Pfizer, Biotech, Healthcare Industry, Plains Resources, Energy, Oil & Gas

Fri Jun 27, 2014

GlobeNewswire

Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa)...

Protalix BioTherapeutics, Inc. , announced today that new clinical data on ELELYSOTM will be presented at the European Working Group on Gaucher Disease 2014 11th Meeting being held June 25-28 in Haifa, Israel.

Comment?

Related Topix: Plains Resources, Energy, Oil & Gas, Medicine, Israel, World News

Thu Sep 19, 2013

Scoop

Easier access funded enzyme replacement therapy

PHARMAC is providing greater funded access to the expensive enzyme replacement therapy imiglucerase , mainly expanding its use in children.

Comment?

Related Topix: Medicine

•••
•••
•••
•••
•••
•••